FEATURES

FEATURES

FEATURES

From hit discovery to ADME/T prediction,
All in one place

From hit discovery to ADME/T prediction,
All in one place

Explore vast space for Greater discovery success

  • Hyper Screening X searches a massive 11-trillion-compound virtual library to uncover novel and diverse molecules.

  • Efficiently navigate an expansive chemical space—unfeasible with traditional virtual screening—using cutting-edge generative AI.

  • The Hyper Screening X library continues to grow, expanding your discovery potential.

Find molecules tailored to your target

  • Why settle for the same AI? Hyper Screening X customizes the AI training to fit your project’s unique needs.

  • Define physicochemical conditions for molecules alongside the target protein.

  • Use trained AI models to generate condition-specific molecules as many times as needed.

Request synthesis quotes and Purchase Building Blocks

  • Easily get synthesis quotes for your generated molecules directly through HyperLab.

  • Browse building block prices, suppliers, and delivery times in one interface.

Leverage the power of the generative AI

  • Hyper Screening X is powered by RxnFlow, a state-of-the-art generative AI for molecule discovery [ICLR 2025].

  • RxnFlow constructs molecules by combining building blocks through chemical reactions, overcoming unnatural structures and low synthesizability issues common in traditional generative AI designs.

  • Flexibly train AI to generate molecules meeting complex conditions, even across countless possibilities.

* Seunghwan Seo et al. ICLR 2025 (arXiv:2410.04542).

Access building blocks and Synthesis routes

  • Hyper Screening X generates molecules using purchasable building blocks and feasible chemical reactions.

  • Generated molecules achieve over 80% synthesizability,* ensuring reliable synthesis outcomes.

* Validated by Synple Chem synthesis service.

Provide a selection of 500 molecules

  • We offer a list of the top 500 molecules based on binding score criteria for the target, along with their binding score and structures.

  • Results can be seen within 24-48 hours for 1 million molecules. 

No need for cumbersome meetings with external vendors

A process that usually takes several months can be completed in just a few days

Easily use the pre-processed library

Provide a selection of 500 molecules

  • We offer a list of the top 500 molecules based on binding score criteria for the target, along with their binding score and structures.

  • Results can be seen within 24-48 hours for 1 million molecules. 

No need for cumbersome meetings with external vendors

A process that usually takes several months can be completed in just a few days

No need for cumbersome meetings with external vendors

Provide a selection of 500 molecules

  • We offer a list of the top 500 molecules based on binding score criteria for the target, along with their binding score and structures.

  • Results can be seen within 24-48 hours for 1 million molecules. 

No need for cumbersome meetings with external vendors

A process that usually takes several months can be completed in just a few days

No need for cumbersome meetings with external vendors

Ready to revolutionize
Your drug discovery process?

Ready to
revolutionize your
drug discovery process?

Ready to revolutionize
Your drug discovery process?

Sign up with your email and start using HyperLab right now

Sign up with your email and start using HyperLab right now

Sign up with your email and start using HyperLab right now

HITS Inc.

CEO : Woo Youn Kim

Address : 8F, 28, Teheran-ro 4-gil, Gangnam-gu, Seoul, Republic of Korea

Tel : +82-2-6953-0317

Company registration number : 260-88-01818

© HITS Inc. All rights reserved.

Address : 8F, 28, Teheran-ro 4-gil, Gangnam-gu, Seoul, Republic of Korea

Tel : +82-2-6953-0317

Company registration number : 260-88-01818

HITS Inc.

CEO : Woo Youn Kim

© HITS Inc. All rights reserved.

HITS Inc.

CEO : Woo Youn Kim

Address : 8F, 28, Teheran-ro 4-gil, Gangnam-gu, Seoul, Republic of Korea

Tel : +82-2-6953-0317

Company registration number : 260-88-01818

© HITS Inc. All rights reserved.